Biote Corp.(BTMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BTMD Biote Corp.

Market Closed 05-17 16:00:00 EDT

5.75

-0.09

-1.54%

盘后5.75

+0.000.00%

18:07 EDT

High5.94	Low5.75	Vol55.35K
Open5.87	D1 Closing5.84	Amplitude3.25%
Mkt Cap165.22M	Tradable Cap63.73M	Total Shares28.73M
T/O322.04K	T/O Rate0.50%	Tradable Shares11.08M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BTMD","market":"US","secType":"STK","nameCN":"Biote Corp.","latestPrice":5.75,"timestamp":1715976000000,"preClose":5.84,"halted":0,"volume":55347,"hourTrading":{"tag":"盘后","latestPrice":5.75,"preClose":5.75,"latestTime":"18:07 EDT","volume":710,"amount":4084.04,"timestamp":1715983664533},"delay":0,"floatShares":11082833,"shares":28733599,"eps":0.268649,"marketStatus":"Market Closed","change":-0.09,"latestTime":"05-17 16:00:00 EDT","open":5.87,"high":5.94,"low":5.75,"amount":322042.8045,"amplitude":0.032534,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.268649,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716192000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":5.84,"postHourTrading":{"tag":"盘后","latestPrice":5.75,"preClose":5.75,"latestTime":"18:07 EDT","volume":710,"amount":4084.04,"timestamp":1715983664533},"volumeRatio":0.6299114963711236},"requestUrl":"/m/hq/s/BTMD","defaultTab":"news","newsList":[{"id":"2433501742","title":"Biote Corp reports results for the quarter ended in March - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2433501742","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2433501742?lang=en_us&edition=fundamental","pubTime":"2024-05-08 19:30","pubTimestamp":1715167823,"startTime":"0","endTime":"0","summary":"* Biote Corp    reported a quarterly adjusted loss of 6 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of -39 cents.  The mean ex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433744500","title":"Q1 2024 Biote Corp Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2433744500","media":"Thomson Reuters StreetEvents","top":-1,"share":"https://ttm.financial/m/news/2433744500?lang=en_us&edition=fundamental","pubTime":"2024-05-08 18:48","pubTimestamp":1715165291,"startTime":"0","endTime":"0","summary":"Good day, and welcome to the Biote first-quarter 2024 earnings conference call.  Please note this event is being recorded. I would now like to turn the conference over to Simon Serowiecki, IR Representative from Advisory Partners. Please go ahead.Thank you, Simon, and thank you all for joining us on the call. With me today is Bob Pearson, our Chi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q1-2024-biote-corp-earnings-104811235.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433675739","title":"Biote Corp. (BTMD) Q1 Earnings Beat Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2433675739","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2433675739?lang=en_us&edition=fundamental","pubTime":"2024-05-08 06:50","pubTimestamp":1715122205,"startTime":"0","endTime":"0","summary":"Biote Corp.  came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.94 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 360%. A quarter ago, it was expected that this company would post earnings of $0.08 per share when it actually produced earnings of $0.14, delivering a surprise of 75%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.biote Corp. , which belongs to the Zacks Medical - Products industry, posted revenues of $46.8 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 0.60%. This compares to year-ago revenues of $44.84 million. The company has topped consensus revenue estimates two times over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/HIalcDlt7JZPKSITVlxPuw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/HIalcDlt7JZPKSITVlxPuw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biote-corp-btmd-q1-earnings-225005619.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433756670","title":"Biote Corp (BTMD) Q1 2024 Earnings: Performance Aligns with Analyst Revenue Projections","url":"https://stock-news.laohu8.com/highlight/detail?id=2433756670","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2433756670?lang=en_us&edition=fundamental","pubTime":"2024-05-08 05:54","pubTimestamp":1715118883,"startTime":"0","endTime":"0","summary":"Revenue: Reported at $46.8 million, up 4.4% year-over-year, slightly exceeding the estimate of $45.71 million.Net Loss: Recorded at $(5.8) million, significantly narrower than the previous year's $ million, though it did not meet the estimated net income of $3.13 million.Earnings Per Share : Reported a loss of $ per share, improved from $ last year but did not meet the estimated earnings of $0.03 per share.Gross Profit Margin: Increased to 71.4% from 69.1% in the prior-year period, indicating more efficient cost management.Operating Income: Rose to $10.4 million from $7.9 million a year ago, reflecting improved operational efficiency.Adjusted EBITDA: Increased to $14.2 million from $13.1 million, with the Adjusted EBITDA margin expanding to 30.2% from 29.2%.On May 7, 2024, Biote Corp , a leader in personalized hormone optimization and therapeutic wellness, released its first quarter financial results, showcasing a stable financial performance with significant strategic developments. Th","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/tZ.r4EHotamT63aulmsHgw--~B/aD01NTc7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/879f10fffad5ef795507f6df8668a298","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/tZ.r4EHotamT63aulmsHgw--~B/aD01NTc7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/879f10fffad5ef795507f6df8668a298"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biote-corp-btmd-q1-2024-215443914.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433753009","title":"Biote Q1 2024 GAAP EPS $(0.06) Misses $0.03 Estimate, Sales $46.804M Beat $45.711M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2433753009","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2433753009?lang=en_us&edition=fundamental","pubTime":"2024-05-08 05:48","pubTimestamp":1715118534,"startTime":"0","endTime":"0","summary":"Biote (NASDAQ:BTMD) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.03 by 300 percent. This is a 84.62 percent increase over losses of $(0.39) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38686438/biote-q1-2024-gaap-eps-0-06-misses-0-03-estimate-sales-46-804m-beat-45-711m-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2433371427","title":"Biote Reports First Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2433371427","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2433371427?lang=en_us&edition=fundamental","pubTime":"2024-05-08 04:05","pubTimestamp":1715112300,"startTime":"0","endTime":"0","summary":"Procedure revenue growth and strengthened profitability drive solid financial performance. Reaffirms 2024 financial guidance, with an acceleration in second half growth. IRVING, Texas, May 07, 2024----Biote , a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the first quarter ended March 31, 2024.Gross profit margin of 71.4%, an approximately 240-basis point increase. Adjusted EBITDA margin1 of 30.2%, a 100-basis point increase. Ms. Weber continued, \"As previously announced, on March 18th, we closed the acquisition of Asteria Health, a manufacturer of compounded bioidentical hormones. We have begun to integrate Asteria Health into our operations, with a goal of achieving full vertical integration of our pellet manufacturing. We believe this strategic acquisition strengthens our competitive position and provides deep expertise in 503 manufacturing, enabling Biot","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biote-reports-first-quarter-2024-200500514.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432337273","title":"Earnings Preview: biote Corp. (BTMD) Q1 Earnings Expected to Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2432337273","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2432337273?lang=en_us&edition=fundamental","pubTime":"2024-04-30 22:00","pubTimestamp":1714485659,"startTime":"0","endTime":"0","summary":"The market expects biote Corp.  to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 7, 2024, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This company is expected to post quarterly earnings of $0.05 per share in its upcoming report, which represents a year-over-year change of -94.7%.Revenues are expected t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Fs_R4sd8jCoOMib958Znmg--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Fs_R4sd8jCoOMib958Znmg--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/earnings-preview-biote-corp-btmd-140059212.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431821345","title":"BRIEF-Biote Corp Definitive Settlement With Co Founder","url":"https://stock-news.laohu8.com/highlight/detail?id=2431821345","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2431821345?lang=en_us&edition=fundamental","pubTime":"2024-04-30 05:28","pubTimestamp":1714426124,"startTime":"0","endTime":"0","summary":"April 29 (Reuters) - biote Corp   :   * BIOTE CORP: DEFINITIVE SETTLEMENT WITH CO FOUNDER   * BIOTE CORP: TO REPURCHASE ALL OF FOUNDER'S 18.4 MILLION SHARES AT $4.17 PER SHARESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431828236","title":"Biote Settles Litigation and Repurchases Shares from Founder","url":"https://stock-news.laohu8.com/highlight/detail?id=2431828236","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2431828236?lang=en_us&edition=fundamental","pubTime":"2024-04-30 04:32","pubTimestamp":1714422751,"startTime":"0","endTime":"0","summary":"biote (BTMD) has shared an announcement. Biote Corp. has reached a settlement with shareholder Dr. Gary S. Donovitz, agreeing to repurchase various...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biote-settles-litigation-and-repurchases-shares-from-founder?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biote-settles-litigation-and-repurchases-shares-from-founder?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2431476798","title":"Biote announces definitive settlement with founder Gary Donovitz","url":"https://stock-news.laohu8.com/highlight/detail?id=2431476798","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431476798?lang=en_us&edition=fundamental","pubTime":"2024-04-30 04:11","pubTimestamp":1714421489,"startTime":"0","endTime":"0","summary":"biote  on Monday said it has entered into a definitive settlement agreement that concludes outstanding litigation with Gary Donovitz, founder and stockholder of the company. The settlement agreement includes a mutual release of all claims relating to litigation between Donovitz and Biote; the termination of the founder advisory agreement by and between Donovitz and BioTE Medical; two year non-compete and non-solicitation agreements for Donovitz; and a voting agreement with customary terms acceptable to the company.  Additionally, Biote will repurchase all 18.4 million shares beneficially held by Donovitz. Under the terms of the Settlement Agreement, Biote will repurchase all of Donovitz’s Biote Class A common units of BioTE Holdings, shares of Class V common stock of the company and shares of Class A common stock for approximately $76.9 million in the aggregate. Source: Press Release","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4095824-biote-announces-definitive-settlement-with-founder-gary-donovitz","is_publish_highlight":false,"gpt_icon":0},{"id":"2431825649","title":"Biote Announces Definitive Settlement with Founder","url":"https://stock-news.laohu8.com/highlight/detail?id=2431825649","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2431825649?lang=en_us&edition=fundamental","pubTime":"2024-04-30 04:05","pubTimestamp":1714421100,"startTime":"0","endTime":"0","summary":"Company to repurchase all of Founder’s 18.4 million shares at $4.17 per share. IRVING, Texas, April 29, 2024----biote Corp.  , a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced it has entered into a definitive settlement agreement  that concludes outstanding litigation with Dr. Gary S. Donovitz , founder and stockholder of Biote.The Settlement Agreement includes a mutual release of all claims relating to litigation between Donovitz and Biote; the termination of the founder advisory agreement by and between Donovitz and BioTE Medical, LLC; two year non-compete and non-solicitation agreements for Donovitz; and a voting agreement with customary terms acceptable to the Company. Additionally, Biote will repurchase all 18.4 million Biote shares beneficially held by Donovitz.Biote is transforming healthy aging through innovative, personalized hormone optimization and therapeutic wellness s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biote-announces-definitive-settlement-founder-200500274.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429142827","title":"Biote Schedules First Quarter 2024 Financial Results Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2429142827","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2429142827?lang=en_us&edition=fundamental","pubTime":"2024-04-24 04:05","pubTimestamp":1713902700,"startTime":"0","endTime":"0","summary":"IRVING, Texas, April 23, 2024----biote Corp.  , a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide first quarter financial results on Tuesday, May 7, 2024, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.The conference call may be accessed by dialing  481-2820  or  317-0679 . The live webcast of the call can be accessed using the following link: biote Corp. First Quarter Earnings Call. A replay of the webcast will be available on the Events page of the Biote Investor Relations website, found here, shortly after the event concludes.Biote is transforming healthy aging through innovative, personalized hormone optimization and therapeutic wellness solutions delivered by Biote-certified medical providers. Biote trains practitioners to identify and treat early indicators of aging conditions, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biote-schedules-first-quarter-2024-200500065.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biote.com","stockEarnings":[{"period":"1week","weight":-0.0605},{"period":"1month","weight":0.0417},{"period":"3month","weight":0.2286},{"period":"6month","weight":0.1569},{"period":"1year","weight":0.0177},{"period":"ytd","weight":0.164}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.040491},{"month":2,"riseRate":0.666667,"avgChangeRate":0.23275},{"month":3,"riseRate":0.666667,"avgChangeRate":0.102394},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.000777},{"month":5,"riseRate":0.25,"avgChangeRate":-0.119832},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.065641},{"month":7,"riseRate":0.666667,"avgChangeRate":0.005979},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.040268},{"month":9,"riseRate":0.666667,"avgChangeRate":0.005643},{"month":10,"riseRate":1,"avgChangeRate":0.03132},{"month":11,"riseRate":0,"avgChangeRate":-0.059725},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.022663}],"exchange":"NASDAQ","name":"Biote Corp.","nameEN":"Biote Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biote Corp.(BTMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biote Corp.(BTMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biote Corp.,BTMD,Biote Corp.股票,Biote Corp.股票老虎,Biote Corp.股票老虎国际,Biote Corp.行情,Biote Corp.股票行情,Biote Corp.股价,Biote Corp.股市,Biote Corp.股票价格,Biote Corp.股票交易,Biote Corp.股票购买,Biote Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biote Corp.(BTMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biote Corp.(BTMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction